newsfilter
← Latest News
GlobeNewswire·

Allogene Therapeutics Announces Participation in September Investor Conference

  • Allogene Therapeutics, Inc. (NASDAQ: ALLO) will participate in the Citi Biopharma Back to School Conference on Wednesday, September 9, 2026.
  • The company's presentation is scheduled for 5:00 a.m. PT (8:00 a.m. ET).
  • Live webcasts & replays will be available on the Company's website at www.allogene.com under the Investors tab.
  • Allogene is a clinical-stage biotechnology company headquartered in South San Francisco focusing on allogeneic CAR T products for cancer & autoimmune disease.
  • The company's pipeline aims to deliver off-the-shelf CAR T cell products more reliably & at greater scale.
  • The press release includes cautionary statements regarding forward-looking assertions about product development, regulatory approval, & commercialization risks.